4148 — All Cosmos Bio-Tech Holding Income Statement

0.000.00%

Last trade - 00:00

Basic MaterialsBalancedSmall CapNeutral

Annual income statement for All Cosmos Bio-Tech Holding, fiscal year end - December 31st, TWD millions except per share, conversion factor applied.

	2020 December 31st	2021 December 31st	2022 December 31st	2023 December 31st	2024 December 31st
Period Length:	12 M	12 M	12 M	12 M	12 M
Source:	Annual Audited Accounts	Annual Audited Accounts	Annual Audited Accounts	Annual Audited Accounts	Annual Audited Accounts
Standards:	IFRS	IFRS	IFRS	IFRS	IFRS
Status:	Final	Final	Final	Final	Final
Revenue
Total Revenue	1,643	2,197	3,702	2,827	2,459
Cost of Revenue
Gross Profit	372	594	1,138	588	669
Selling / General / Administrative Expenses
Research And Development
Depreciation and Amortization
Unusual Expense / Income
Total Operating Expenses	1,540	1,924	3,035	2,637	2,298
Operating Profit	103	273	667	190	161
Gain / Loss on Sale of Assets
Total Net Non Operating Interest Income / Expense
Other Net Non Operating Costs
Net Income Before Taxes	150	322	634	258	253
Provision for Income Taxes
Net Income After Taxes	98.2	237	456	189	174
Minority Interest
Net Income Before Extraordinary Items
Net Income	82.2	198	368	139	129
Income Available to Common Shareholders Excluding Extraordinary Items
Income Available to Common Shareholders Including Extraordinary Items
Dilution Adjustment
Diluted Net Income	82.2	198	373	151	125
Diluted Weighted Average Shares
Basic EPS Including Extraordinary Items
Diluted EPS Including Extraordinary Items
Diluted EPS Excluding Extraordinary Items
Normalised Income Before Taxes
Normalised Income After Taxes
Normalised Income Available to Common Shareholders
Diluted Normalised EPS	1.22	2.94	5.38	2.03	1.78
Dividends per Share